Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
Z67HvuvGUWwYnYEF